Information about medicinal products published on this website is provided for informational purposes only and does not constitute advertising, a public offer, an offer for sale, or instructions for use.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.
DIFERELIN (FRANCE)
1 vial contains triptorelin acetate, equivalent to 3.75 mg of triptorelin.
Composition
Active ingredient: triptorelin
Dosage form
Powder and solvent for prolonged-release suspension for injection.
Pharmacological group
Gonadotropin-releasing hormone analogs.
Indications
Prostate cancer. Treatment of localized prostate cancer alone or as an adjunct and adjuvant therapy in combination with radiotherapy.
Treatment of metastatic prostate cancer.
Genital and extragenital endometriosis (stages I-IV).
Female infertility.
Precocious puberty in children.
To be taken as prescribed by a doctor.
Active ingredient: triptorelin
Dosage form
Powder and solvent for prolonged-release suspension for injection.
Pharmacological group
Gonadotropin-releasing hormone analogs.
Indications
Prostate cancer. Treatment of localized prostate cancer alone or as an adjunct and adjuvant therapy in combination with radiotherapy.
Treatment of metastatic prostate cancer.
Genital and extragenital endometriosis (stages I-IV).
Female infertility.
Precocious puberty in children.
To be taken as prescribed by a doctor.
